PUNCTATE INNER CHOROIDOPATHY–LIKE REACTIONS IN UNRELATED RETINAL DISEASES
医学
眼科
视网膜色素上皮
萎缩
视网膜
病理
作者
Maria Vittoria Cicinelli,Alessandro Marchese,Prithvi Ramtohul,Elisabetta Miserocchi,Ugo Introini,Francesco Bandello,K. Bailey Freund,Maurízio Battaglia Parodi
出处
期刊:Retina-the Journal of Retinal and Vitreous Diseases [Ovid Technologies (Wolters Kluwer)] 日期:2022-10-21卷期号:42 (11): 2099-2109被引量:13
Purpose: To report a cohort of patients with a punctate inner choroidopathy (PIC)-like reaction in concurrent, unrelated, chorioretinal disorders. Methods: This was a retrospective observational study of patients seen at two referral centers with lesions consistent with PIC on multimodal imaging; patients with lesions resembling idiopathic multifocal choroiditis were also included. Active PIC-like lesions appeared as focal hyperreflective lesions splitting the retinal pigment epithelium/Bruch membrane (RPE/BrM) complex on optical coherence tomography. Chronic PIC-like lesions included subretinal fibrosis, multifocal punched-out chorioretinal atrophy, and curvilinear streaks. Patients' demographics, additional imaging features, and treatment responses were collected and summarized. Results: Twenty-two eyes of 16 patients with a PIC-like reaction were included (75% females; median age 40 years). Underlying diagnoses included hereditary retinal conditions (10 patients, 63%) and acquired etiologies, all characterized by the RPE/BrM or outer retinal disruption. Fifteen eyes (68%) had active PIC-like lesions; seven eyes (32%) had chronic PIC-like lesions. Active PIC-like lesions regressed with time and responded to systemic steroids. Subretinal fibrosis (3 eyes, 20%), macular atrophy (3 eyes, 20%), and concomitant subretinal fibrosis and macular atrophy (5 eyes, 33%) developed on follow-up. Recurrences occurred in five eyes (23%). Conclusion: RPE/BrM or outer retina disruption may trigger a PIC-like reaction in susceptible patients, presumably because of the loss of immune privilege. A PIC-like reaction may influence the clinical progression and the visual prognosis of the primary chorioretinal disease.